tiprankstipranks
Trending News
More News >
ACADIA Pharmaceuticals Inc. (ACAD)
:ACAD
US Market

ACADIA Pharmaceuticals (ACAD) Ownership - Who Owns ACADIA Pharmaceuticals?

Compare
2,349 Followers

ACADIA Pharmaceuticals (ACAD) Ownership Overview

24.00%15.31%2.32%24.89%33.48%
24.00% Insiders
2.32% Other Institutional Investors
24.89% ETFs
33.48% Public Companies and Individual Investors
The ownership structure of ACADIA Pharmaceuticals (ACAD) stock is a mix of institutional, retail, and individual investors. Approximately 42.52% of the company’s stock is owned by Institutional Investors, 24.00% is owned by Insiders, and 33.48% is owned by Public Companies and Individual Investors.
The ownership structure of ACADIA Pharmaceuticals (ACAD) stock is a mix of institutional, retail, and individual investors. Approximately 17.63% of the company’s stock is owned by Institutional Investors, 24.00% is owned by Insiders, and 24.89% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 05, 2025
xxxxxxxxxxxxx
$314634
Mar 06, 2025
xxxxxxxxxxxxx
$89673

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$1639174
Mar 31, 2025
xxxxxxxxxxxxx
$4903438
Mar 31, 2025
xxxxxxxxxxxxx
$5896898

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
42,877,916Institution25.62%930,879,556
39,571,717Insider23.64%859,101,976
14,567,440Institution8.70%316,259,122
12,569,173Institution7.51%272,876,746
10,722,984Institution6.41%232,795,983
4,151,300Institution2.48%90,124,723
2,428,553Institution1.45%52,723,886
2,160,114Institution1.29%46,896,075
1,679,735Institution1.00%36,467,047
1,276,714Institution0.76%27,717,461

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
10,722,984Institution6.41%232,795,983
1,276,714Institution0.76%27,717,461
1,246,122Institution0.74%27,053,309
1,059,550Institution0.63%23,002,831
892,845Institution0.53%19,383,665
827,725Institution0.49%17,969,910
827,716Institution0.49%17,969,714
761,969Institution0.46%16,542,347
758,178Institution0.45%16,460,044
666,804Institution0.40%14,476,315

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
7,364,145Institution4.40%159,875,588
4,005,544Institution2.39%58,480,942
3,133,352Institution1.87%45,746,939
3,022,043Institution1.81%65,608,554
2,193,687Institution1.31%47,690,755
2,167,383Institution1.30%47,053,885
1,913,763Institution1.14%27,940,940
1,743,998Institution1.04%25,462,371
1,517,636Institution0.91%32,993,407
1,045,389Institution0.62%22,726,757

FAQ

Who Owns ACADIA Pharmaceuticals Inc. (ACAD)?
According to the latest TipRanks data, approximately 2.32% of the company's stock is held by institutional investors, 24.00% is held by insiders, and 33.48% is held by retail investors.
    What percentage of ACADIA Pharmaceuticals Inc. (ACAD) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.32% of ACADIA Pharmaceuticals Inc. (ACAD) stock is held by institutional investors.
      What percentage of ACADIA Pharmaceuticals Inc. (ACAD) stock is held by retail investors?
      According to the latest TipRanks data, approximately 33.48% of ACADIA Pharmaceuticals Inc. (ACAD) stock is held by retail investors.
        Who owns the most shares of ACADIA Pharmaceuticals Inc. (ACAD)?
        Felix Baker owns the most shares of ACADIA Pharmaceuticals Inc. (ACAD).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis